Prophylactic lamivudine use was associated with a significantly reduced rate of HBV reactivation in patients treated for HCC with 3D-CRT compared with patients without prophylaxis, including a lowered incidence of RILD (12.5% vs 21.8%), although this difference did not reach statistical significance [ 39 ].
← all excerpts
Strategies for prediction and mitigation of radiation-induced liver toxicity.
1
—
—